We focus on development of new therapies against diseases where cells age too fast, mainly because of chromosome instability. AMP is the first company to develop a patented family of human peptides as a therapeutic product candidate able to increase Telomerase activity in senescent cells, in vivo. Telomerase is a molecular complex of very difficult biomedical manipulation; its role is to maintain the length of telomeres, which are special DNA sequences located at...

We are interested in stopping and reverting the molecular clock in human cells. By doing this, we aim to treat many human diseases where aging happens too fast, including rare diseases such as Progeria, Werner Syndrome, etc; also there are other not so rare diseases where some particular cells degenerate too fast following an abnormally accelerated aging molecular program, including Idiopathic Pulmonary Fibrosis. Advanced Medical Projects is a biotechnology company...

Advanced Medical Projects is a small biotechnology holding of companies interested in DNA stability, aging and disease. We follow a “bottom-up” approach to research, so we study many different aspects of aging, telomerase function and chromosome stability to understand basic biological and physiological areas. Once we understand basic principles, we look for mechanisms able to act over some particular biochemical and genetic pathway. Founded in 2010 A spin-off...

Advanced Medical Projects is a small holding of biotechnology and biocosmetics companies. Our scientific focus is in DNA stability and its role in disease and aging. Since we are very interested in developing therapies against cancer and other diseases, diagnostics and delivery are also areas we work actively in. Finally, trying to cure diseases related to senescence, we discovered that our molecules have an amazing potential to slow down normal aging, which makes...

CANCER. Cancer is ultimately the result of cells that uncontrollably grow and do not die. Normal cells in the body follow an orderly path of growth, division, and death. Programmed cell death is called apoptosis, and when this process breaks down, cancer begins to form. Unlike regular cells, cancer cells do not experience programmatic death and instead continue to grow and divide. This leads to a mass of abnormal cells that grows out of control. Telomerase is the...